Details for New Drug Application (NDA): 083080
✉ Email this page to a colleague
NDA 083080 describes AQUASOL A, which is a drug marketed by Astrazeneca and Casper Pharma Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the AQUASOL A profile page.
The generic ingredient in AQUASOL A is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.
The generic ingredient in AQUASOL A is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.
Summary for 083080
| Tradename: | AQUASOL A |
| Applicant: | Astrazeneca |
| Ingredient: | vitamin a |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083080
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50,000USP UNITS | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 25,000USP UNITS | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
